The EMCDDA, as part of its ongoing commitment to strengthening cooperation and sharing expertise, has developed the EU4Monitoring Drugs (EU4MD) project. Funded by the European Union, the project will run from 2019 until the end of 2021 and will involve countries in the European Neighbourhood Policy (ENP) area. Read more about the project >>
By filling out this form, you agree to receiving quarterly e-mail updates about the EU4MD project.
* indicates required